Celcuity Inc. Reports Third Quarter Financial Results and Provides Corporate Update
The PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 trial is 100% enrolled; expect to report topline data for this cohort in late Q1 2025 or Q2 2025Approximately $264 million in cash, cash ...
'Campus activism that veers into hate speech.' UR prof, Schumer condemn 'wanted' posters
Hundreds of "wanted" posters covered a tunnel beneath the University of Rochester campus Sunday night, accusing a handful of ...